Niger has reached over three-quarters of a million women with modern contraception
New report shows that 314 million women and girls are now using modern contraception in 69 low income countries
News Topic: Integrating FP & HIV Services
Over 3 million women and girls are using modern methods of contraception as Nepal continues to step up efforts
New report shows that 314 million women and girls are now using modern contraception in 69 low income countries
Mozambique is consistently fastest growing country for uptake of modern methods of contraception since 2012
New report shows that 314 million women and girls are now using modern contraception in 69 low income countries
WHO Updates MEC Guidance on Contraceptive Method Eligibility for Women at High Risk of HIV Transmission
The World Health Organization (WHO) has updated its MEC guidance on contraceptive method eligibility for women at high risk of HIV transmission, based on the results of the recent ECHO study.
Controversy Erupts Around Study on Contraception and HIV Risk
A landmark study evaluating HIV risk and hormonal contraception is under fire, with critics arguing the trial was ethically flawed from the start and that its results may limit already narrow birth-control options for African women.
South African activist champions for wider contraceptive choices for women
African women need greater choices when it comes to the provision of contraceptives, a South African AIDS activist has told a panel at the ninth South African AIDS Conference in Durban.
New study finds no link between HIV infection and contraceptive methods
A large clinical research study conducted in four African countries found no significant difference in risk of HIV infection among women using one of three highly effective, reversible contraceptive methods.
HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial
Observational and laboratory studies suggest that some hormonal contraceptive methods, particularly intramuscular depot medroxyprogesterone acetate (DMPA-IM), might increase women's susceptibility to HIV acquisition. We aimed to compare DMPA-IM, a copper intrauterine device (IUD), and a levonorgestrel (LNG) implant among African women seeking effective contraception and living in areas of high HIV incidence.
Joint Statement from APHA, AVAC, FP2020, ICWEA, PAI and PPFA: An Urgent Need to Prioritize Woman-Centered and Integrated Contraception and HIV Prevention and Treatment Options
ECHO Trial Results Released: Press Coverage
Today at a satellite symposium at the South African AIDS Conference, the ECHO trial of contraceptive use and impact on HIV risk released its results.
